Sanara MedTech PE Ratio 2014-2025 | SMTI
Current and historical p/e ratio for Sanara MedTech (SMTI) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sanara MedTech PE ratio as of July 23, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Sanara MedTech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-23 | 27.38 | 0.00 | |
| 2025-03-31 | 30.87 | $-1.34 | 0.00 |
| 2024-12-31 | 33.20 | $-1.14 | 0.00 |
| 2024-09-30 | 30.24 | $-0.99 | 0.00 |
| 2024-06-30 | 28.22 | $-0.78 | 0.00 |
| 2024-03-31 | 37.00 | $-0.59 | 0.00 |
| 2023-12-31 | 41.10 | $-0.52 | 0.00 |
| 2023-09-30 | 31.13 | $-1.00 | 0.00 |
| 2023-06-30 | 40.10 | $-1.05 | 0.00 |
| 2023-03-31 | 41.25 | $-1.25 | 0.00 |
| 2022-12-31 | 45.50 | $-1.52 | 0.00 |
| 2022-09-30 | 29.69 | $-1.49 | 0.00 |
| 2022-06-30 | 20.86 | $-1.58 | 0.00 |
| 2022-03-31 | 28.48 | $-1.32 | 0.00 |
| 2021-12-31 | 29.55 | $-1.08 | 0.00 |
| 2021-09-30 | 34.29 | $-0.64 | 0.00 |
| 2021-06-30 | 36.95 | $-0.55 | 0.00 |
| 2021-03-31 | 31.15 | $-0.57 | 0.00 |
| 2020-12-31 | 49.90 | $-0.79 | 0.00 |
| 2020-09-30 | 28.00 | $-1.29 | 0.00 |
| 2020-06-30 | 18.00 | $-1.46 | 0.00 |
| 2020-03-31 | 10.09 | $-1.43 | 0.00 |
| 2019-12-31 | 16.10 | $-1.04 | 0.00 |
| 2019-09-30 | 8.50 | $-0.50 | 0.00 |
| 2019-06-30 | 5.51 | $-0.15 | 0.00 |
| 2019-03-31 | 5.95 | 0 | 0.00 |
| 2018-12-31 | 3.27 | 0 | 0.00 |
| 2018-09-30 | 6.99 | 0 | 0.00 |
| 2018-06-30 | 6.50 | 0 | 0.00 |
| 2018-03-31 | 4.82 | 0 | 0.00 |
| 2017-12-31 | 6.00 | 0 | 0.00 |
| 2017-09-30 | 7.00 | 0 | 0.00 |
| 2017-06-30 | 7.80 | 0 | 0.00 |
| 2017-03-31 | 9.10 | $-1.00 | 0.00 |
| 2016-12-31 | 3.79 | $-1.00 | 0.00 |
| 2016-09-30 | 4.20 | $-1.00 | 0.00 |
| 2016-06-30 | 6.95 | $-1.00 | 0.00 |
| 2016-03-31 | 7.50 | $-1.00 | 0.00 |
| 2015-12-31 | 8.85 | $-1.00 | 0.00 |
| 2015-09-30 | 7.24 | $-1.00 | 0.00 |
| 2015-06-30 | 9.10 | $-1.00 | 0.00 |
| 2015-03-31 | 6.20 | 0 | 0.00 |
| 2014-12-31 | 5.50 | 0 | 0.00 |
| 2014-09-30 | 9.00 | 0 | 0.00 |
| 2014-06-30 | 10.60 | 0 | 0.00 |
| 2014-03-31 | 11.50 | 0 | 0.00 |
| 2013-12-31 | 10.50 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.234B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.750B | 25.66 |
| Boston Scientific (BSX) | United States | $152.620B | 38.21 |
| Stryker (SYK) | United States | $150.824B | 31.54 |
| EssilorLuxottica (ESLOY) | France | $131.932B | 0.00 |
| Medtronic (MDT) | Ireland | $117.545B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.596B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.351B | 24.74 |
| ResMed (RMD) | United States | $39.208B | 29.45 |
| GE HealthCare Technologies (GEHC) | United States | $35.024B | 16.63 |
| Agilent Technologies (A) | United States | $33.005B | 21.52 |
| Koninklijke Philips (PHG) | Netherlands | $24.092B | 16.91 |
| Terumo (TRUMY) | Japan | $23.645B | 30.71 |
| Insulet (PODD) | United States | $20.097B | 78.89 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.096B | 12.26 |
| Baxter (BAX) | United States | $14.117B | 10.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.680B | 23.25 |
| Lantheus Holdings (LNTH) | United States | $5.005B | 12.62 |
| Perrigo (PRGO) | Ireland | $3.788B | 9.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Haemonetics (HAE) | United States | $3.565B | 16.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.397B | 28.23 |
| ICU Medical (ICUI) | United States | $3.107B | 22.91 |
| LeMaitre Vascular (LMAT) | United States | $1.816B | 40.60 |
| QuidelOrtho (QDEL) | United States | $1.727B | 11.88 |
| AtriCure (ATRC) | United States | $1.454B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.279B | 12.99 |
| Green Thumb Industries (GTBIF) | United States | $1.243B | 27.96 |
| Phibro Animal Health (PAHC) | United States | $1.185B | 15.15 |
| Neogen (NEOG) | United States | $1.090B | 13.94 |
| BioLife Solutions (BLFS) | United States | $1.024B | 0.00 |
| InMode (INMD) | Israel | $0.911B | 9.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.874B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.791B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.784B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.644B | 0.00 |
| Owens & Minor (OMI) | United States | $0.626B | 5.19 |
| Evolus (EOLS) | United States | $0.617B | 0.00 |
| CeriBell (CBLL) | United States | $0.561B | 0.00 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.456B | 0.00 |
| SNDL (SNDL) | Canada | $0.431B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.312B | 11.48 |
| Cresco Labs (CRLBF) | United States | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 84.17 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.273B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.67 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.220B | 0.00 |
| Omeros (OMER) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| TriSalus Life Sciences (TLSI) | United States | $0.170B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.153B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.32 |
| TerrAscend (TSNDF) | Canada | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.11 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.14 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |